Username

Password

Preview

Sign-in free and Explore the Exciting World of BiomedExperts:

Over 1.500.000 Profiles
More than 1.800 Organizations worldwide
State of the Art Network Visualizations

Manage your own Profile
Locate Experts in your Country/Region
Locate Experts in your 1. and 2. Level Network
Connect to Experts Worldwide

NetworkView

Helio Sader

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Chemicals & Drugs

Physiology

Living Beings

Geographic Areas

Disorders

Concepts & Ideas

Sentinel Surveillance

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Jones Ronald N; Stilwell Matthew G; Rhomberg Paul R; Sader Helio S
Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997-2007).
Moet Gary J; Watters Amy A; Sader Helio S; Jones Ronald N
Expanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lots.
Sader Helio S; Jones Ronald N; Rossi Kerri L; Rybak Michael J
Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Helio Sader (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Jones Ronald N; Stilwell Matthew G; Rhomberg Paul R; Sader Helio S
Antipseudomonal activity of piperacillin/tazobactam: more than a decade of experience from the SENTRY Antimicrobial Surveillance Program (1997-2007).
Diagnostic microbiology and infectious disease 2009;65(3):331-4.
2009: Moet Gary J; Watters Amy A; Sader Helio S; Jones Ronald N
Expanded studies of piperacillin/tazobactam formulations: variations among branded product lots and assessment of 46 generic lots.
Diagnostic microbiology and infectious disease 2009;65(3):319-22.
2009: Sader Helio S; Jones Ronald N; Rossi Kerri L; Rybak Michael J
Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.
The Journal of antimicrobial chemotherapy 2009;64(5):1024-8.
2009: Mathai Dilip; Biedenbach Douglas J; Jones Ronald N; Bell Jan M; Turnidge John; Sader Helio S;
Activity of daptomycin against gram-positive bacterial isolates from Indian medical centres (2006-2007).
International journal of antimicrobial agents 2009;34(5):497-9.
2009: Sader Helio S; Jones Ronald N
Antimicrobial susceptibility of Gram-positive bacteria isolated from US medical centers: results of the Daptomycin Surveillance Program (2007-2008).
Diagnostic microbiology and infectious disease 2009;65(2):158-62.
2009: Sader Helio S; Fey Paul D; Fish Douglas N; Limaye Ajit P; Pankey George; Rahal James; Rybak Michael J; Snydman David R; Steed Lisa L; Waites Ken; Jones Ronald N
Evaluation of vancomycin and daptomycin potency trends (MIC creep) against methicillin-resistant Staphylococcus aureus isolates collected in nine U.S. medical centers from 2002 to 2006.
Antimicrobial agents and chemotherapy 2009;53(10):4127-32.
2009: Sader Helio S; Rhomberg Paul R; Jones Ronald N
Nine-hospital study comparing broth microdilution and Etest method results for vancomycin and daptomycin against methicillin-resistant Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2009;53(7):3162-5.
2009: Swenson Jana M; Brasso William B; Ferraro Mary Jane; Hardy Dwight J; Knapp Cynthia C; Lonsway David; McAllister Sigrid; Reller L Barth; Sader Helio S; Shortridge Dee; Skov Robert; Weinstein Melvin P; Zimmer Barbara L; Patel Jean B
Correlation of cefoxitin MICs with the presence of mecA in Staphylococcus spp.
Journal of clinical microbiology 2009;47(6):1902-5.
2009: Vidaillac Céline; Leonard Steve N; Sader Helio S; Jones Ronald N; Rybak Michael J
In vitro activity of ceftaroline alone and in combination against clinical isolates of resistant gram-negative pathogens, including beta-lactamase-producing Enterobacteriaceae and Pseudomonas aeruginosa.
Antimicrobial agents and chemotherapy 2009;53(6):2360-6.
2009: Sader Helio S; Fritsche Thomas R; Jones Ronald N
Potency and bactericidal activity of iclaprim against recent clinical gram-positive isolates.
Antimicrobial agents and chemotherapy 2009;53(5):2171-5.
2009: Fritsche Thomas R; Sader Helio S; Stillwell Matthew G; Jones Ronald N
Antimicrobial activity of doripenem tested against prevalent Gram-positive pathogens: results from a global surveillance study (2003-2007).
Diagnostic microbiology and infectious disease 2009;63(4):440-6.
2009: Jones Ronald N; Bell Jan M; Sader Helio S; Turnidge John D; Stilwell Matthew G
In vitro potency of doripenem tested against an international collection of rarely isolated bacterial pathogens.
Diagnostic microbiology and infectious disease 2009;63(4):434-9.
2009: Mendes Rodrigo E; Rhomberg Paul R; Bell Jan M; Turnidge John D; Sader Helio S
Doripenem activity tested against a global collection of Enterobacteriaceae, including isolates resistant to other extended-spectrum agents.
Diagnostic microbiology and infectious disease 2009;63(4):415-25.
2009: Jones Ronald N; Moet Gary J; Sader Helio S; Mendes Rodrigo E; Castanheira Mariana
TR-700 in vitro activity against and resistance mutation frequencies among Gram-positive pathogens.
The Journal of antimicrobial chemotherapy 2009;63(4):716-20.
2009: Morfin-Otero Rayo; Rodriguez-Noriega Eduardo; Deshpande Lalitagauri M; Sader Helio S; Castanheira Mariana
Dissemination of a bla(VIM-2)-Carrying Integron Among Enterobacteriaceae Species in Mexico: Report from the SENTRY Antimicrobial Surveillance Program.
Microbial drug resistance (Larchmont, N.Y.) 2009;15(1):33-5.
2009: Jones Ronald N; Biedenbach Douglas J; Sader Helio S
In vitro activity of iclaprim and comparison agents tested against Neisseria gonorrhoeae including medium growth supplement effects.
Diagnostic microbiology and infectious disease 2009;63(3):339-41.
2009: Biedenbach Douglas J; Bell Jan M; Sader Helio S; Turnidge John D; Jones Ronald N
Activities of dalbavancin against a worldwide collection of 81,673 gram-positive bacterial isolates.
Antimicrobial agents and chemotherapy 2009;53(3):1260-3.
2009: Sader Helio S; Fritsche Thomas R; Jones Ronald N
Antimicrobial activity of daptomycin and selected comparators tested against bloodstream Staphylococcus aureus isolates from hemodialysis patients.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2009;13(2):291-5.
2008: Sader Helio S; Koeth Laura M; Poupard James A; Jones Ronald N
Interpretive categorical accuracy of fluoroquinolone reference broth microdilution MIC results when testing Streptococcus pneumoniae: selection of a surrogate testing agent.
Diagnostic microbiology and infectious disease 2008;62(4):460-3.
2008: Jones Ronald N; Fritsche Thomas R; Sader Helio S
Antimicrobial activity of DC-159a, a new fluoroquinolone, against 1,149 recently collected clinical isolates.
Antimicrobial agents and chemotherapy 2008;52(10):3763-75.
2008: Garza-Ramos U; Morfin-Otero R; Sader H S; Jones R N; Hernández E; Rodriguez-Noriega E; Sanchez A; Carrillo B; Esparza-Ahumada S; Silva-Sanchez J
Metallo-beta-lactamase gene bla(IMP-15) in a class 1 integron, In95, from Pseudomonas aeruginosa clinical isolates from a hospital in Mexico.
Antimicrobial agents and chemotherapy 2008;52(8):2943-6.
2008: Martin Craig A; Morita Kazumi; Ribes Julie A; Deshpande Lalitagauri M; Sader Helio S; Castanheira Mariana
IMP-15-producing Pseudomonas aeruginosa strain isolated in a U.S. medical center: a recent arrival from Mexico.
Antimicrobial agents and chemotherapy 2008;52(6):2289-90.
2008: Castanheira Mariana; Jones Ronald N; Sader Hélio S
Update of the in vitro activity of daptomycin tested against 6710 Gram-positive cocci isolated in North America (2006).
Diagnostic microbiology and infectious disease 2008;61(2):235-9.
2008: Fritsche Thomas R; Sader Helio S; Jones Ronald N
Antimicrobial activity of ceftobiprole, a novel anti-methicillin-resistant Staphylococcus aureus cephalosporin, tested against contemporary pathogens: results from the SENTRY Antimicrobial Surveillance Program (2005-2006).
Diagnostic microbiology and infectious disease 2008;61(1):86-95.
2008: Fritsche Thomas R; Rhomberg Paul R; Sader Helio S; Jones Ronald N
Antimicrobial activity of omiganan pentahydrochloride tested against contemporary bacterial pathogens commonly responsible for catheter-associated infections.
The Journal of antimicrobial chemotherapy 2008;61(5):1092-8.
2008: Mendes Rodrigo E; Fritsche Thomas R; Sader Helio S; Jones Ronald N
Increased antimicrobial susceptibility profiles among polymyxin-resistant Acinetobacter baumannii clinical isolates.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2008;46(8):1324-6.
2008: Castanheira Mariana; Fritsche Thomas R; Sader Hélio S; Jones Ronald N
RmtD 16S RNA methylase in epidemiologically unrelated spm-1-producing Pseudomonas aeruginosa isolates from Brazil.
Antimicrobial agents and chemotherapy 2008;52(4):1587-8; author reply 1588.
2008: Fritsche Thomas R; Rhomberg Paul R; Sader Helio S; Jones Ronald N
In vitro activity of omiganan pentahydrochloride tested against vancomycin-tolerant, -intermediate, and -resistant Staphylococcus aureus.
Diagnostic microbiology and infectious disease 2008;60(4):399-403.
2008: Gales Ana C; Sader Helio S; Fritsche Thomas R
Tigecycline activity tested against 11808 bacterial pathogens recently collected from US medical centers.
Diagnostic microbiology and infectious disease 2008;60(4):421-7.
2008: Mendes Rodrigo E; Sader Helio S; Deshpande Lalitagauri; Jones Ronald N
Antimicrobial activity of tigecycline against community-acquired methicillin-resistant Staphylococcus aureus isolates recovered from North American medical centers.
Diagnostic microbiology and infectious disease 2008;60(4):433-6.
2008: Sader Helio S; Fritsche Thomas R; Jones Ronald N
Antimicrobial activities of Ceftaroline and ME1036 tested against clinical strains of community-acquired methicillin-resistant Staphylococcus aureus.
Antimicrobial agents and chemotherapy 2008;52(3):1153-5.
2008: Fritsche Thomas R; Rhomberg Paul R; Sader Helio S; Jones Ronald N
Antimicrobial activity of omiganan pentahydrochloride against contemporary fungal pathogens responsible for catheter-associated infections.
Antimicrobial agents and chemotherapy 2008;52(3):1187-9.
2008: Galles A C; Jones R N; Sader H S
Antimicrobial susceptibility profile of contemporary clinical strains of Stenotrophomonas maltophilia isolates: can moxifloxacin activity be predicted by levofloxacin MIC results?
Journal of chemotherapy (Florence, Italy) 2008;20(1):38-42.
2008: Sader H S; Watters A A; Fritsche T R; Jones R N
Activity of daptomycin and selected antimicrobial agents tested against Staphylococcus aureus from patients with bloodstream infections hospitalized in European medical centers.
Journal of chemotherapy (Florence, Italy) 2008;20(1):28-32.
2008: Chin Judy N; Jones Ronald N; Sader Helio S; Savage Paul B; Rybak Michael J
Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa.
The Journal of antimicrobial chemotherapy 2008;61(2):365-70.
2008: Castanheira Mariana; Sader Hélio S; Deshpande Lalitagauri M; Fritsche Thomas R; Jones Ronald N
Antimicrobial activities of tigecycline and other broad-spectrum antimicrobials tested against serine carbapenemase- and metallo-beta-lactamase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program.
Antimicrobial agents and chemotherapy 2008;52(2):570-3.
2008: Garza-Ramos U; Tinoco P; Silva-Sanchez J; Morfin-Otero R; Rodriguez-Noriega E; Leon-Garnica G; Sader H S; Jones R N
Metallo-beta-lactamase IMP-18 is located in a class 1 integron (In96) in a clinical isolate of Pseudomonas aeruginosa from Mexico.
International journal of antimicrobial agents 2008;31(1):78-80.
2007: Jones Ronald N; Sader Helio S; Fritsche Thomas R; Janechek Michael J
Selection of a surrogate beta-lactam testing agent for initial susceptibility testing of doripenem, a new carbapenem.
Diagnostic microbiology and infectious disease 2007;59(4):467-72.
2007: Sader Helio S; Mallick Rajiv; Kuznik Andreas; Fritsche Thomas R; Jones Ronald N
Use of in vitro susceptibility and pathogen prevalence data to model the expected clinical success rates of tigecycline and other commonly used antimicrobials for empirical treatment of complicated skin and skin-structure infections.
International journal of antimicrobial agents 2007;30(6):514-20.
2007: Swenson Jana M; Brasso William B; Ferraro Mary Jane; Hardy Dwight J; Knapp Cynthia C; McDougal Linda K; Reller L Barth; Sader Helio S; Shortridge Dee; Skov Robert; Weinstein Melvin P; Zimmer Barbara L; Patel Jean B
Detection of inducible clindamycin resistance in staphylococci by broth microdilution using erythromycin-clindamycin combination wells.
Journal of clinical microbiology 2007;45(12):3954-7.
2007: Tato M; Coque T M; Ruíz-Garbajosa P; Pintado V; Cobo J; Sader H S; Jones R N; Baquero F; Cantón R
Complex clonal and plasmid epidemiology in the first outbreak of Enterobacteriaceae infection involving VIM-1 metallo-beta-lactamase in Spain: toward endemicity?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2007;45(9):1171-8.
2007: Jones Ronald N; Fritsche Thomas R; Sader Helio S; Ross James E
LEADER surveillance program results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from the United States (50 medical centers).
Diagnostic microbiology and infectious disease 2007;59(3):309-17.
2007: Jones Ronald N; Fritsche Thomas R; Sader Helio S; Ross James E
Zyvox Annual Appraisal of Potency and Spectrum Program Results for 2006: an activity and spectrum analysis of linezolid using clinical isolates from 16 countries.
Diagnostic microbiology and infectious disease 2007;59(2):199-209.
2007: Biedenbach Douglas J; Bell Jan M; Sader Helio S; Fritsche Thomas R; Jones Ronald N; Turnidge John D
Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
International journal of antimicrobial agents 2007;30(2):143-9.
2007: Mendes Rodrigo E; Castanheira Mariana; Toleman Mark A; Sader Helio S; Jones Ronald N; Walsh Timothy R
Characterization of an integron carrying blaIMP-1 and a new aminoglycoside resistance gene, aac(6')-31, and its dissemination among genetically unrelated clinical isolates in a Brazilian hospital.
Antimicrobial agents and chemotherapy 2007;51(7):2611-4.
2007: Curcio Daniel; Fernández Francisco; Jones Ronald N; Ferraro Mary Jane; Reller L Barth; Schreckenberger Paul C; Sader Helio S
Tigecycline disk diffusion breakpoints of Acinetobacter spp.: a clinical point of view.
Journal of clinical microbiology 2007;45(6):2095; author reply 2095-6.
2007: Jones Ronald N; Sader Helio S; Stilwell Matthew G; Fritsche Thomas R
Garenoxacin activity against isolates form patients hospitalized with community-acquired pneumonia and multidrug-resistant Streptococcus pneumoniae.
Diagnostic microbiology and infectious disease 2007;58(1):1-7.
2007: Jones Ronald N; Fritsche Thomas R; Sader Helio S; Stilwell Matthew G
Activity of garenoxacin, an investigational des-F(6)-quinolone, tested against pathogens from community-acquired respiratory tract infections, including those with elevated or resistant-level fluoroquinolone MIC values.
Diagnostic microbiology and infectious disease 2007;58(1):9-17.
2007: Sader Helio S; Fritsche Thomas R; Jones Ronald N
In vitro activity of garenoxacin tested against a worldwide collection of ciprofloxacin-susceptible and ciprofloxacin-resistant Enterobacteriaceae strains (1999-2004).
Diagnostic microbiology and infectious disease 2007;58(1):27-32.
2007: Fritsche Thomas R; Sader Helio S; Jones Ronald N
Potency and spectrum of garenoxacin tested against an international collection of skin and soft tissue infection pathogens: report from the SENTRY antimicrobial surveillance program (1999-2004).
Diagnostic microbiology and infectious disease 2007;58(1):19-26.
2007: Sader Helio S; Ferraro Mary J; Reller L Barth; Schreckenberger Paul C; Swenson Jana M; Jones Ronald N
Reevaluation of Clinical and Laboratory Standards Institute disk diffusion breakpoints for tetracyclines for testing Enterobacteriaceae.
Journal of clinical microbiology 2007;45(5):1640-3.
2007: Pfaller Michael A; Sader Helio S; Jones Ronald N
Evaluation of the in vitro activity of daptomycin against 19615 clinical isolates of Gram-positive cocci collected in North American hospitals (2002-2005).
Diagnostic microbiology and infectious disease 2007;57(4):459-65.
2007: Sader Helio S; Jacobs Michael R; Fritsche Thomas R
Review of the spectrum and potency of orally administered cephalosporins and amoxicillin/clavulanate.
Diagnostic microbiology and infectious disease 2007;57(3 Suppl):5S-12S.
2007: Ross James E; Fritsche Thomas R; Sader Helio S; Jones Ronald N
Oxazolidinone susceptibility patterns for 2005: International Report from the Zyvox Annual Appraisal of Potency and Spectrum Study.
International journal of antimicrobial agents 2007;29(3):295-301.
2007: Biedenbach Douglas J; Ross James E; Fritsche Thomas R; Sader Helio S; Jones Ronald N
Activity of dalbavancin tested against Staphylococcus spp. and beta-hemolytic Streptococcus spp. isolated from 52 geographically diverse medical centers in the United States.
Journal of clinical microbiology 2007;45(3):998-1004.
2007: Sader Helio S; Hsiung Andre; Fritsche Thomas R; Jones Ronald N
Comparative activities of cefepime and piperacillin/tazobactam tested against a global collection of Escherichia coli and Klebsiella spp. with an ESBL phenotype.
Diagnostic microbiology and infectious disease 2007;57(3):341-4.
2007: Pottumarthy Sudha; Sader Helio S; Jones Ronald N
Bactericidal activity of cefepime and ceftriaxone tested against Streptococcus pneumoniae.
Diagnostic microbiology and infectious disease 2007;57(3):345-9.
2007: Pereira Andrea S; Andrade Soraya S; Monteiro Jussimara; Sader Helio S; Pignatari Antonio C C; Gales Ana C
Evaluation of the susceptibility profiles, genetic similarity and presence of qnr gene in Escherichia coli resistant to ciprofloxacin isolated in Brazilian hospitals.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2007;11(1):40-3.
2007: Sader H S; Bhavnani S M; Ambrose P G; Jones R N; Pfaller M A
Re-evaluation of the role of broad-spectrum cephalosporins against staphylococci by applying contemporary in-vitro results and pharmacokinetic-pharmacodynamic principles.
Journal of chemotherapy (Florence, Italy) 2007;19(1):38-43.
2007: Sader Helio S; Jones Ronald N
Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections.
Expert review of anti-infective therapy 2007;5(1):29-43.
2007: Aboufaycal H; Sader H S; Rolston K; Deshpande L M; Toleman M; Bodey G; Raad I; Jones R N
blaVIM-2 and blaVIM-7 carbapenemase-producing Pseudomonas aeruginosa isolates detected in a tertiary care medical center in the United States: report from the MYSTIC program.
Journal of clinical microbiology 2007;45(2):614-5.
2007: Jones Ronald N; Ferraro Mary Jane; Reller L Barth; Schreckenberger Paul C; Swenson Jana M; Sader Helio S
Multicenter studies of tigecycline disk diffusion susceptibility results for Acinetobacter spp.
Journal of clinical microbiology 2007;45(1):227-30.
2007: Jones Ronald N; Sader Helio S; Fritsche Thomas R; Pottumarthy Sudha
Comparisons of parenteral broad-spectrum cephalosporins tested against bacterial isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Diagnostic microbiology and infectious disease 2007;57(1):109-16.
2007: Castanheira Mariana; Sader Hélio S; Jones Ronald N; Debbia Eugenio; Picão Renata C; Gales Ana C
In71, an Enterobacter cloacae blaVIM-1-carrying integron related to In70.2 from Italian Pseudomonas aeruginosa isolates: a SENTRY Antimicrobial Surveillance Program report.
Microbial drug resistance (Larchmont, N.Y.) 2007;13(2):130-4.
2007: Sader Helio S; Watters Amy A; Fritsche Thomas R; Jones Ronald N
Daptomycin antimicrobial activity tested against methicillin-resistant staphylococci and vancomycin-resistant enterococci isolated in European medical centers (2005).
BMC infectious diseases 2007;7():29.
2006: Deshpande Lalitagauri M; Jones Ronald N; Fritsche Thomas R; Sader Helio S
Occurrence of plasmidic AmpC type beta-lactamase-mediated resistance in Escherichia coli: report from the SENTRY Antimicrobial Surveillance Program (North America, 2004).
International journal of antimicrobial agents 2006;28(6):578-81.
2006: Deshpande Lalitagauri M; Rhomberg Paul R; Sader Helio S; Jones Ronald N
Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005).
Diagnostic microbiology and infectious disease 2006;56(4):367-72.
2006: Andrade Soraya S; Sader Helio S; Jones Ronald N; Pereira Andrea S; Pignatari Antônio C C; Gales Ana C
Increased resistance to first-line agents among bacterial pathogens isolated from urinary tract infections in Latin America: time for local guidelines?
Memórias do Instituto Oswaldo Cruz 2006;101(7):741-8.
2006: Ribeiro J; Mendes R E; Domingos R; França E; Silbert S; Jones R N; Sader H S
Microbiological and epidemiological characterization of imipenem-resistant Pseudomonas aeruginosa strains from a Brazilian tertiary hospital: report from the SENTRY Antimicrobial Surveillance Program.
Journal of chemotherapy (Florence, Italy) 2006;18(5):461-7.
2006: Deshpande Lalitagauri M; Sader Helio S; Fritsche Thomas R; Jones Ronald N
Contemporary prevalence of BRO beta-lactamases in Moraxella catarrhalis: report from the SENTRY antimicrobial surveillance program (North America, 1997 to 2004).
Journal of clinical microbiology 2006;44(10):3775-7.
2006: Sader Helio S; Jones Ronald N
The activity of daptomycin against wild-type Staphylococcus aureus and strains with reduced susceptibility to vancomycin.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;43(6):798-9; author reply 799-800.
2006: Sader H S; Streit J M; Fritsche T R; Jones R N
Antimicrobial susceptibility of gram-positive bacteria isolated from European medical centres: results of the Daptomycin Surveillance Programme (2002-2004).
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2006;12(9):844-52.
2006: Pfaller Michael A; Sader Helio S; Fritsche Thomas R; Jones Ronald N
Antimicrobial activity of cefepime tested against ceftazidime-resistant Gram-negative clinical strains from North American Hospitals: report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Diagnostic microbiology and infectious disease 2006;56(1):63-8.
2006: Rhomberg Paul R; Fritsche Thomas R; Sader Helio S; Jones Ronald N
Antimicrobial susceptibility pattern comparisons among intensive care unit and general ward Gram-negative isolates from the Meropenem Yearly Susceptibility Test Information Collection Program (USA).
Diagnostic microbiology and infectious disease 2006;56(1):57-62.
2006: Mariani Paul G; Sader Helio S; Jones Ronald N
Development of decreased susceptibility to daptomycin and vancomycin in a Staphylococcus aureus strain during prolonged therapy.
The Journal of antimicrobial chemotherapy 2006;58(2):481-3.
2006: Jones Ronald N; Sader Helio S
Update on the cefdinir spectrum and potency against pathogens isolated from uncomplicated skin and soft tissue infections in North America: are we evaluating the orally administered cephalosporins correctly?
Diagnostic microbiology and infectious disease 2006;55(4):351-6.
2006: Jones Ronald N; Sader Helio S; Fritsche Thomas R; Hogan Patricia A; Sheehan Daniel J
Selection of a surrogate agent (vancomycin or teicoplanin) for initial susceptibility testing of dalbavancin: results from an international antimicrobial surveillance program.
Journal of clinical microbiology 2006;44(7):2622-5.
2006: Tognim Maria C B; Gales Ana C; Penteado Andréia P; Silbert Suzane; Sader Hélio S
Dissemination of IMP-1 metallo- beta -lactamase-producing Acinetobacter species in a Brazilian teaching hospital.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2006;27(7):742-7.
2006: Jones Ronald N; Fritsche Thomas R; Sader Helio S; Ross James E
Activity of retapamulin (SB-275833), a novel pleuromutilin, against selected resistant gram-positive cocci.
Antimicrobial agents and chemotherapy 2006;50(7):2583-6.
2006: Sader Helio S; Fritsche Thomas R; Jones Ronald N
Daptomycin bactericidal activity and correlation between disk and broth microdilution method results in testing of Staphylococcus aureus strains with decreased susceptibility to vancomycin.
Antimicrobial agents and chemotherapy 2006;50(7):2330-6.
2006: Johnson David M; Fritsche Thomas R; Sader Helio S; Jones Ronald N
Evaluation of dalbavancin in combination with nine antimicrobial agents to detect enhanced or antagonistic interactions.
International journal of antimicrobial agents 2006;27(6):557-60.
2006: Fedler Kelley A; Jones Ronald N; Sader Helio S; Fritsche Thomas R
Activity of gatifloxacin tested against isolates from pediatric patients: report from the SENTRY Antimicrobial Surveillance Program (North America, 1998-2003).
Diagnostic microbiology and infectious disease 2006;55(2):157-64.
2006: Watters Amy A; Jones Ronald N; Leeds Jennifer A; Denys Gerald; Sader Helio S; Fritsche Thomas R
Antimicrobial activity of a novel peptide deformylase inhibitor, LBM415, tested against respiratory tract and cutaneous infection pathogens: a global surveillance report (2003-2004).
The Journal of antimicrobial chemotherapy 2006;57(5):914-23.
2006: Gales Ana C; Sader Hélio S; Andrade Soraya S; Lutz Larissa; Machado Adão; Barth Afonso L
Emergence of linezolid-resistant Staphylococcus aureus during treatment of pulmonary infection in a patient with cystic fibrosis.
International journal of antimicrobial agents 2006;27(4):300-2.
2006: Gales A C; Jones R N; Sader H S
Global assessment of the antimicrobial activity of polymyxin B against 54 731 clinical isolates of Gram-negative bacilli: report from the SENTRY antimicrobial surveillance programme (2001-2004).
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2006;12(4):315-21.
2006: Rhomberg Paul R; Fritsche Thomas R; Sader Helio S; Jones Ronald N
Clonal occurrences of multidrug-resistant Gram-negative bacilli: report from the Meropenem Yearly Susceptibility Test Information Collection Surveillance Program in the United States (2004).
Diagnostic microbiology and infectious disease 2006;54(4):249-57.
2006: Sader Helio S; Fritsche Thomas R; Jones Ronald N
Accuracy of three automated systems (MicroScan WalkAway, VITEK, and VITEK 2) for susceptibility testing of Pseudomonas aeruginosa against five broad-spectrum beta-lactam agents.
Journal of clinical microbiology 2006;44(3):1101-4.
2006: Deshpande Lalitagauri M; Sader Helio S; Debbia Eugenio; Nicoletti Giuseppe; Fadda Giovanni; Jones Ronald N;
Emergence and epidemiology of fluoroquinolone-resistant Streptococcus pneumoniae strains from Italy: report from the SENTRY Antimicrobial Surveillance Program (2001-2004).
Diagnostic microbiology and infectious disease 2006;54(3):157-64.
2006: Jones Ronald N; Stilwell Matthew G; Sader Helio S; Fritsche Thomas R; Goldstein Beth P
Spectrum and potency of dalbavancin tested against 3322 Gram-positive cocci isolated in the United States Surveillance Program (2004).
Diagnostic microbiology and infectious disease 2006;54(2):149-53.
2006: Jones Ronald N; Ross James E; Fritsche Thomas R; Sader Helio S
Oxazolidinone susceptibility patterns in 2004: report from the Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program assessing isolates from 16 nations.
The Journal of antimicrobial chemotherapy 2006;57(2):279-87.
2006: Marra A R; Pereira C A P; Castelo A; do Carmo Filho J R; Cal R G R; Sader H S; Wey S B
Health and economic outcomes of the detection of Klebsiella pneumoniae-produced extended-spectrum beta-lactamase (ESBL) in a hospital with high prevalence of this infection.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2006;10(1):56-60.
2006: Jones Ronald N; Sader Helio S; Fritsche Thomas R; Rhomberg Paul R
Carbapenem susceptibility discords among Acinetobacter isolates.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2006;42(1):158.
2006: Deshpande Lalitagauri M; Jones Ronald N; Fritsche Thomas R; Sader Helio S
Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004).
Microbial drug resistance (Larchmont, N.Y.) 2006;12(4):223-30.
2006: Freitas Maria Cecília S; Pacheco-Silva Alvaro; Barbosa Dulce; Silbert Suzane; Sader Hélio; Sesso Ricardo; Camargo Luis Fernando A
Prevalence of vancomycin-resistant Enterococcus fecal colonization among kidney transplant patients.
BMC infectious diseases 2006;6():133.
2006: Castanheira Mariana; Gales Ana C; Pignatari Antonio C C; Jones Ronald N; Sader Hélio S
Changing antimicrobial susceptibility patterns among Streptococcus pneumoniae and Haemophilus influenzae from Brazil: Report from the SENTRY Antimicrobial Surveillance Program (1998-2004).
Microbial drug resistance (Larchmont, N.Y.) 2006;12(2):91-8.
2005: Sader H S; Rhomberg P R; Jones R N
In vitro activity of beta-lactam antimicrobial agents in combination with aztreonam tested against metallo-beta-lactamase-producing Pseudomonas aeruginosa and Acinetobacter baumannii.
Journal of chemotherapy (Florence, Italy) 2005;17(6):622-7.
2005: Jones R N; Fritsche T R; Sader H S; Goldstein B P
Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocol.
Journal of chemotherapy (Florence, Italy) 2005;17(6):593-600.
2005: Sader Helio S; Fritsche Thomas R; Jones Ronald N
Antimicrobial activity of daptomycin tested against clinical strains of indicated species isolated in North American medical centers (2003).
Diagnostic microbiology and infectious disease 2005;53(4):329-32.
2005: Jones Ronald N; Fritsche Thomas R; Ge Yigong; Kaniga Koné; Sader Helio S
Evaluation of PPI-0903M (T91825), a novel cephalosporin: bactericidal activity, effects of modifying in vitro testing parameters and optimization of disc diffusion tests.
The Journal of antimicrobial chemotherapy 2005;56(6):1047-52.
2005: Streit Jennifer M; Sader Helio S; Fritsche Thomas R; Jones Ronald N
Dalbavancin activity against selected populations of antimicrobial-resistant Gram-positive pathogens.
Diagnostic microbiology and infectious disease 2005;53(4):307-10.
2005: Pottumarthy Sudha; Sader Helio S; Fritsche Thomas R; Jones Ronald N
Susceptibility patterns for amoxicillin/clavulanate tests mimicking the licensed formulations and pharmacokinetic relationships: do the MIC obtained with 2:1 ratio testing accurately reflect activity against beta-lactamase-producing strains of Haemophilus influenzae and Moraxella catarrhalis?
Diagnostic microbiology and infectious disease 2005;53(3):225-31.
2005: Gales Ana C; Jones Ronald N; Andrade Soraya S; Pereira Andrea S; Sader Hélio S
In vitro activity of tigecycline, a new glycylcycline, tested against 1,326 clinical bacterial strains isolated from Latin America.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2005;9(5):348-56.
2005: Sader H S; Fritsche T R; Streit J M; Jones R N
Daptomycin in vitro activity tested against Gram-positive strains collected from European and Latin American medical centers in 2003.
Journal of chemotherapy (Florence, Italy) 2005;17(5):477-83.
2005: Rhomberg P R; Fritsche T R; Sader H S; Jones R N
Comparative antimicrobial potency of meropenem tested against Gram-negative bacilli: report from the MYSTIC surveillance program in the United States (2004).
Journal of chemotherapy (Florence, Italy) 2005;17(5):459-69.
2005: Gales Ana C; Jones Ronald N; Andrade Soraya S; Sader Helio S
Antimicrobial susceptibility patterns of unusual nonfermentative gram-negative bacilli isolated from Latin America: report from the SENTRY Antimicrobial Surveillance Program (1997-2002).
Memórias do Instituto Oswaldo Cruz 2005;100(6):571-7.
2005: Pottumarthy Sudha; Yu Yunson; Sader Helio S; Jones Ronald N; Chen Minjun
Susceptibility testing accuracy of a CTX-M-type extended-spectrum beta-lactamase organism-producing population of Enterobacteriaceae: intermethod analysis for 9 beta-lactams.
Diagnostic microbiology and infectious disease 2005;53(2):131-41.
2005: Sader Helio S; Fritsche Thomas R; Kaniga Koné; Ge Yigong; Jones Ronald N
Antimicrobial activity and spectrum of PPI-0903M (T-91825), a novel cephalosporin, tested against a worldwide collection of clinical strains.
Antimicrobial agents and chemotherapy 2005;49(8):3501-12.
2005: Fritsche Thomas R; Sader Helio S; Toleman Mark A; Walsh Timothy R; Jones Ronald N
Emerging metallo-beta-lactamase-mediated resistances: a summary report from the worldwide SENTRY antimicrobial surveillance program.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2005;41 Suppl 4():S276-8.
2005: Sader Helio S; Fritsche Thomas R; Jones Ronald N
Potency and spectrum trends for cefepime tested against 65746 clinical bacterial isolates collected in North American medical centers: results from the SENTRY Antimicrobial Surveillance Program (1998-2003).
Diagnostic microbiology and infectious disease 2005;52(3):265-73.
2005: Fritsche Thomas R; Strabala Patty A; Sader Helio S; Dowzicky Michael J; Jones Ronald N
Activity of tigecycline tested against a global collection of Enterobacteriaceae, including tetracycline-resistant isolates.
Diagnostic microbiology and infectious disease 2005;52(3):209-13.
2005: Sader Helio S; Jones Ronald N; Dowzicky Michael J; Fritsche Thomas R
Antimicrobial activity of tigecycline tested against nosocomial bacterial pathogens from patients hospitalized in the intensive care unit.
Diagnostic microbiology and infectious disease 2005;52(3):203-8.
2005: Fritsche Thomas R; Sader Helio S; Stilwell Matthew G; Dowzicky Michael J; Jones Ronald N
Potency and spectrum of tigecycline tested against an international collection of bacterial pathogens associated with skin and soft tissue infections (2000-2004).
Diagnostic microbiology and infectious disease 2005;52(3):195-201.
2005: Fritsche Thomas R; Sader Helio S; Stilwell Matthew G; Dowzicky Michael J; Jones Ronald N
Antimicrobial activity of tigecycline tested against organisms causing community-acquired respiratory tract infection and nosocomial pneumonia.
Diagnostic microbiology and infectious disease 2005;52(3):187-93.
2005: Sader Helio S; Jones Ronald N; Stilwell Matthew G; Dowzicky Michael J; Fritsche Thomas R
Tigecycline activity tested against 26,474 bloodstream infection isolates: a collection from 6 continents.
Diagnostic microbiology and infectious disease 2005;52(3):181-6.
2005: Anderegg Tamara R; Sader Helio S; Fritsche Thomas R; Ross James E; Jones Ronald N
Trends in linezolid susceptibility patterns: report from the 2002-2003 worldwide Zyvox Annual Appraisal of Potency and Spectrum (ZAAPS) Program.
International journal of antimicrobial agents 2005;26(1):13-21.
2005: Jones Ronald N; Fritsche Thomas R; Sader Helio S
Therapeutic options among broad-spectrum beta-lactams for infections caused by levofloxacin-nonsusceptible Streptococcus pneumoniae.
Diagnostic microbiology and infectious disease 2005;52(2):129-33.
2005: Pottumarthy Sudha; Deshpande Lalitagauri M; Sader Helio S; Jones Ronald N
Reevaluation of the cefepime minimal inhibitory concentrations and disk diffusion test zone diameter relationship for a worldwide collection of Enterobacteriaceae enriched for extended-spectrum beta-lactamase-producing organisms.
Diagnostic microbiology and infectious disease 2005;52(2):95-9.
2005: Jones Ronald N; Sader Helio S; Fritsche Thomas R
Comparative activity of doripenem and three other carbapenems tested against Gram-negative bacilli with various beta-lactamase resistance mechanisms.
Diagnostic microbiology and infectious disease 2005;52(1):71-4.
2005: Ross James E; Anderegg Tamara R; Sader Helio S; Fritsche Thomas R; Jones Ronald N
Trends in linezolid susceptibility patterns in 2002: report from the worldwide Zyvox Annual Appraisal of Potency and Spectrum Program.
Diagnostic microbiology and infectious disease 2005;52(1):53-8.
2005: Sader Helio S; Jones Ronald N
Comprehensive in vitro evaluation of cefepime combined with aztreonam or ampicillin/sulbactam against multi-drug resistant Pseudomonas aeruginosa and Acinetobacter spp.
International journal of antimicrobial agents 2005;25(5):380-4.
2005: Fritsche Thomas R; Sader Helio S; Cleeland Roy; Jones Ronald N
Comparative antimicrobial characterization of LBM415 (NVP PDF-713), a new peptide deformylase inhibitor of clinical importance.
Antimicrobial agents and chemotherapy 2005;49(4):1468-76.
2005: Pottumarthy Sudha; Fritsche Thomas R; Sader Helio S; Stilwell Matthew G; Jones Ronald N
Susceptibility patterns of Streptococcus pneumoniae isolates in North America (2002-2003): contemporary in vitro activities of amoxicillin/clavulanate and 15 other antimicrobial agents.
International journal of antimicrobial agents 2005;25(4):282-9.
2005: Ross James E; Sader Helio S; Fritsche Thomas R; Jones Ronald N
Reproducibility of gemifloxacin and comparison fluoroquinolone MIC results using Sensititre commercial dry-form panels.
Diagnostic microbiology and infectious disease 2005;51(3):219-21.
2005: Rhomberg Paul R; Sader Helio S; Jones Ronald N
Reproducibility of daptomycin MIC results using dry-form commercial trays with appropriate supplemental calcium content.
International journal of antimicrobial agents 2005;25(3):274-6.
2005: Jones Ronald N; Sader Helio S; Fritsche Thomas R
Antimicrobial activity of LBM415 (NVP PDF-713) tested against pathogenic Neisseria spp. (Neisseria gonorrhoeae and Neisseria meningitidis).
Diagnostic microbiology and infectious disease 2005;51(2):139-41.
2005: Jones Ronald N; Biedenbach Douglas J; Sader Helio S; Fritsche Thomas R; Toleman Mark A; Walsh Timothy R
Emerging epidemic of metallo-beta-lactamase-mediated resistances.
Diagnostic microbiology and infectious disease 2005;51(2):77-84.
2005: Gales A C; Sader H S; Jones R N
Antimicrobial activity of dalbavancin tested against Gram-positive clinical isolates from Latin American medical centres.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2005;11(2):95-100.
2005: Sader Helio S; Jones Ronald N
Antimicrobial susceptibility of uncommonly isolated non-enteric Gram-negative bacilli.
International journal of antimicrobial agents 2005;25(2):95-109.
2005: Sader H S; Reis A O; Silbert S; Gales A C
IMPs, VIMs and SPMs: the diversity of metallo-beta-lactamases produced by carbapenem-resistant Pseudomonas aeruginosa in a Brazilian hospital.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2005;11(1):73-6.
2005: Sader Helio S; Biedenbach Douglas J; Streit Jennifer M; Jones Ronald N
Cefdinir activity against contemporary North American isolates from community-acquired urinary tract infections.
International journal of antimicrobial agents 2005;25(1):89-92.
2005: Sader Helio S; Castanheira Mariana; Mendes Rodrigo E; Toleman Mark; Walsh Timothy R; Jones Ronald N
Dissemination and diversity of metallo-beta-lactamases in Latin America: report from the SENTRY Antimicrobial Surveillance Program.
International journal of antimicrobial agents 2005;25(1):57-61.
2004: Messer Shawn A; Kirby Jeffrey T; Sader Helio S; Fritsche Thomas R; Jones Ronald N
Initial results from a longitudinal international surveillance programme for anidulafungin (2003).
The Journal of antimicrobial chemotherapy 2004;54(6):1051-6.
2004: Mendes Rodrigo E; Toleman Mark A; Ribeiro Julival; Sader Helio S; Jones Ronald N; Walsh Timothy R
Integron carrying a novel metallo-beta-lactamase gene, blaIMP-16, and a fused form of aminoglycoside-resistant gene aac(6')-30/aac(6')-Ib': report from the SENTRY Antimicrobial Surveillance Program.
Antimicrobial agents and chemotherapy 2004;48(12):4693-702.
2004: Sader Helio S; Streit Jennifer M; Fritsche Thomas R; Jones Ronald N
Antimicrobial activity of daptomycin against multidrug-resistant Gram-positive strains collected worldwide.
Diagnostic microbiology and infectious disease 2004;50(3):201-4.
2004: Silbert Suzane; Pfaller Michael A; Hollis Richard J; Barth Afonso L; Sader Hélio S
Evaluation of three molecular typing techniques for nonfermentative Gram-negative bacilli.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2004;25(10):847-51.
2004: Yu Wen-Liang; Winokur Patricia L; Jones Ronald N; Sader Hélio S
Surveillance in Taiwan using molecular epidemiology for extended-spectrum beta-lactamase-producing Klebsiella pneumoniae.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2004;25(10):812-8.
2004: Deshpande Lalitagauri; Rhomberg Paul R; Fritsche Thomas R; Sader Helio S; Jones Ronald N
Bactericidal activity of BAL9141, a novel parenteral cephalosporin against contemporary Gram-positive and Gram-negative isolates.
Diagnostic microbiology and infectious disease 2004;50(1):73-5.
2004: Tognim Maria Cristina Bronharo; Andrade Soraya Sgambatti; Silbert Suzane; Gales Ana Cristina; Jones Ronald N; Sader Hélio S
Resistance trends of Acinetobacter spp. in Latin America and characterization of international dissemination of multi-drug resistant strains: five-year report of the SENTRY Antimicrobial Surveillance Program.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2004;8(5):284-91.
2004: Gales A C; Andrade S S; Sader H S; Jones R N
Activity of mupirocin and 14 additional antibiotics against staphylococci isolated from Latin American hospitals: report from the SENTRY antimicrobial surveillance program.
Journal of chemotherapy (Florence, Italy) 2004;16(4):323-8.
2004: Sader Helio S; Streit Jennifer M; Fritsche Thomas R; Jones Ronald N
Potency and spectrum reevaluation of cefdinir tested against pathogens causing skin and soft tissue infections: a sample of North American isolates.
Diagnostic microbiology and infectious disease 2004;49(4):283-7.
2004: Rhomberg Paul R; Jones Ronald N; Sader Helio S; Fritsche Thomas R;
Antimicrobial resistance rates and clonality results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) programme: report of year five (2003).
Diagnostic microbiology and infectious disease 2004;49(4):273-81.
2004: Streit Jennifer M; Jones Ronald N; Sader Helio S; Fritsche Thomas R
Assessment of pathogen occurrences and resistance profiles among infected patients in the intensive care unit: report from the SENTRY Antimicrobial Surveillance Program (North America, 2001).
International journal of antimicrobial agents 2004;24(2):111-8.
2004: Sader Helio S; Fedler Kelley A; Rennie Robert P; Stevens Shelley; Jones Ronald N
Omiganan pentahydrochloride (MBI 226), a topical 12-amino-acid cationic peptide: spectrum of antimicrobial activity and measurements of bactericidal activity.
Antimicrobial agents and chemotherapy 2004;48(8):3112-8.
2004: Barbosa Dulce; Lima Lidimara; Silbert Suzane; Sader Hélio; Cendoroglo Miguel; Draibe Sergio; Camargo Luis; Vianna Lucila; Belasco Angelica; Sesso Ricardo
Evaluation of the prevalence and risk factors for colonization by vancomycin-resistant Enterococcus among patients on dialysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2004;44(2):337-43.
2004: Jones Ronald N; Deshpande Lalitagauri; Fritsche Thomas R; Sader Helio S
Determination of epidemic clonality among multidrug-resistant strains of Acinetobacter spp. and Pseudomonas aeruginosa in the MYSTIC Programme (USA, 1999-2003).
Diagnostic microbiology and infectious disease 2004;49(3):211-6.
2004: Anderegg T R; Jones R N; Sader H S;
Quality control guidelines for BAL9141 (Ro 63-9141), an investigational cephalosporin, when reference MIC and standardized disk diffusion susceptibility test methods are used.
Journal of clinical microbiology 2004;42(7):3356-8.
2004: Castanheira M; Gales A C; Mendes R E; Jones R N; Sader H S
Antimicrobial susceptibility of Streptococcus pneumoniae in Latin America: results from five years of the SENTRY Antimicrobial Surveillance Program.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(7):645-51.
2004: Jones Ronald N; Huynh Holly K; Biedenbach Douglas J; Fritsche Thomas R; Sader Helio S
Doripenem (S-4661), a novel carbapenem: comparative activity against contemporary pathogens including bactericidal action and preliminary in vitro methods evaluations.
The Journal of antimicrobial chemotherapy 2004;54(1):144-54.
2004: Mendes C; Kiffer C R V; Blosser-Middleton R S; Jones M E; Karlowsky J A; Barth A; Rossi F; Andrade S; Sader H S; Thornsberry C; Sahm D F;
Antimicrobial susceptibility to levofloxacin and other antibacterial agents among common respiratory pathogens-a Brazilian perspective from the GLOBAL Surveillance Initiative 2001-2002.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(6):521-6.
2004: Jones Ronald N; Sader Helio S; Fritsche Thomas R
Doxycycline use for community-acquired pneumonia: contemporary in vitro spectrum of activity against Streptococcus pneumoniae (1999-2002).
Diagnostic microbiology and infectious disease 2004;49(2):147-9.
2004: Jones Ronald N; Fritsche Thomas R; Sader Helio S
Antimicrobial spectrum and activity of NVP PDF-713, a novel peptide deformylase inhibitor, tested against 1,837 recent Gram-positive clinical isolates.
Diagnostic microbiology and infectious disease 2004;49(1):63-5.
2004: Jones Ronald N; Moet Gary J; Sader Helio S; Fritsche Thomas R
Potential utility of a peptide deformylase inhibitor (NVP PDF-713) against oxazolidinone-resistant or streptogramin-resistant Gram-positive organism isolates.
The Journal of antimicrobial chemotherapy 2004;53(5):804-7.
2004: Streit Jennifer M; Jones Ronald N; Sader Helio S
Daptomycin activity and spectrum: a worldwide sample of 6737 clinical Gram-positive organisms.
The Journal of antimicrobial chemotherapy 2004;53(4):669-74.
2004: Suffredini I B; Sader H S; Gonçalves A G; Reis A O; Gales A C; Varella A D; Younes R N
Screening of antibacterial extracts from plants native to the Brazilian Amazon Rain Forest and Atlantic Forest.
Brazilian journal of medical and biological research = Revista brasileira de pesquisas médicas e biológicas / Sociedade Brasileira de Biofísica ... [et al.] 2004;37(3):379-84.
2004: Cordeiro J C R; Silbert S; Reis A O; Sader H S
Inter-hospital dissemination of glycopeptide-resistant Enterococcus faecalis in Brazil.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10(3):260-2.
2004: Sader Helio S; Jones Ronald N; Gales Ana C; Silva Juliana B; Pignatari Antonio C;
SENTRY antimicrobial surveillance program report: Latin American and Brazilian results for 1997 through 2001.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2004;8(1):25-79.
2004: Streit Jennifer M; Fritsche Thomas R; Sader Helio S; Jones Ronald N
Worldwide assessment of dalbavancin activity and spectrum against over 6,000 clinical isolates.
Diagnostic microbiology and infectious disease 2004;48(2):137-43.
2004: Mutnick Alan H; Rhomberg Paul R; Sader Helio S; Jones Ronald N
Antimicrobial usage and resistance trend relationships from the MYSTIC Programme in North America (1999-2001).
The Journal of antimicrobial chemotherapy 2004;53(2):290-6.
2004: Rhomberg Paul R; Jones Ronald N; Sader Helio S;
Results from the Meropenem Yearly Susceptibility Test Information Collection (MYSTIC) Programme: report of the 2001 data from 15 United States medical centres.
International journal of antimicrobial agents 2004;23(1):52-9.
2004: Kirby Jeffrey T; Sader Helio S; Walsh Timothy R; Jones Ronald N
Antimicrobial susceptibility and epidemiology of a worldwide collection of Chryseobacterium spp: report from the SENTRY Antimicrobial Surveillance Program (1997-2001).
Journal of clinical microbiology 2004;42(1):445-8.
2004: Sader Helio S; Johnson David M; Jones Ronald N
In vitro activities of the novel cephalosporin LB 11058 against multidrug-resistant Staphylococci and Streptococci.
Antimicrobial agents and chemotherapy 2004;48(1):53-62.
2004: Gales Ana Cristina; Pfaller Michael A; Sader Helio S; Hollis Richard J; Jones Ronald N
Genotypic characterization of carbapenem-nonsusceptible Acinetobacter spp. isolated in Latin America.
Microbial drug resistance (Larchmont, N.Y.) 2004;10(4):286-91.
2003: Jones Ronald N; Sader Helio S; Beach Mondell L
Contemporary in vitro spectrum of activity summary for antimicrobial agents tested against 18569 strains non-fermentative Gram-negative bacilli isolated in the SENTRY Antimicrobial Surveillance Program (1997-2001).
International journal of antimicrobial agents 2003;22(6):551-6.
2003: Tosin Iraci; Silbert Suzane; Sader Helio S
The use of molecular typing to evaluate the dissemination of antimicrobial resistance among Gram-negative rods in Brazilian hospitals.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2003;7(6):360-9.
2003: Sader Helio S; Huynh Holly K; Jones Ronald N
Contemporary in vitro synergy rates for aztreonam combined with newer fluoroquinolones and beta-lactams tested against gram-negative bacilli.
Diagnostic microbiology and infectious disease 2003;47(3):547-50.
2003: Sader Helio S; Fritsche Thomas R; Mutnick Alan H; Jones Ronald N
Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002).
Diagnostic microbiology and infectious disease 2003;47(3):515-25.
2003: Mendes Rodrigo E; Reis Adriana O; Gales Ana C; Jones Ronald N; Sader Hélio S
Ability of Latin America laboratories to detect antimicrobial resistance patterns: experience of the SENTRY Antimicrobial Surveillance Program (1997-2000).
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2003;7(5):282-9.
2003: Fritsche Thomas R; Sader Helio S; Jones Ronald N
Comparative activity and spectrum of broad-spectrum beta-lactams (cefepime, ceftazidime, ceftriaxone, piperacillin/tazobactam) tested against 12,295 staphylococci and streptococci: report from the SENTRY antimicrobial surveillance program (North America: 2001-2002).
Diagnostic microbiology and infectious disease 2003;47(2):435-40.
2003: Gales Ana C; Menezes Liana C; Silbert Suzane; Sader Hélio S
Dissemination in distinct Brazilian regions of an epidemic carbapenem-resistant Pseudomonas aeruginosa producing SPM metallo-beta-lactamase.
The Journal of antimicrobial chemotherapy 2003;52(4):699-702.
2003: Gordon Kelley A; Sader Helio S; Jones Ronald N
Contemporary re-evaluation of the activity and spectrum of grepafloxacin tested against isolates in the United States.
Diagnostic microbiology and infectious disease 2003;47(1):377-83.
2003: Johnson D M; Sader H S; Fritsche T R; Biedenbach D J; Jones Ronald N
Susceptibility trends of haemophilus influenzae and Moraxella catarrhalis against orally administered antimicrobial agents: five-year report from the SENTRY Antimicrobial Surveillance Program.
Diagnostic microbiology and infectious disease 2003;47(1):373-6.
2003: Sader Helio S; Biedenbach Douglas J; Jones Ronald N
Global patterns of susceptibility for 21 commonly utilized antimicrobial agents tested against 48,440 Enterobacteriaceae in the SENTRY Antimicrobial Surveillance Program (1997-2001).
Diagnostic microbiology and infectious disease 2003;47(1):361-4.
2003: Reis Adriana O; Luz Deise A M; Tognim Maria C B; Sader Hélio S; Gales Ana C
Polymyxin-resistant Acinetobacter spp. isolates: what is next?
Emerging infectious diseases 2003;9(8):1025-7.
2003: Andrade Soraya S; Jones Ronald N; Gales Ana C; Sader Helio S
Increasing prevalence of antimicrobial resistance among Pseudomonas aeruginosa isolates in Latin American medical centres: 5 year report of the SENTRY Antimicrobial Surveillance Program (1997-2001).
The Journal of antimicrobial chemotherapy 2003;52(1):140-1.
2003: Grinbaum Renato Satovschi; Guimarães Thaís; Kusano Elisa; Hosino Nair; Sader Helio; Cereda Rosangela Ferraz
A pseudo-outbreak of vancomycin-resistant Enterococcus faecium.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2003;24(6):461-4.
2003: Andrade-Baiocchi Soraya; Tognim Maria Cristina B; Baiocchi Otavio C G; Sader Helio S
Endocarditis due to glycopeptide-intermediate Staphylococcus aureus: case report and strain characterization.
Diagnostic microbiology and infectious disease 2003;45(2):149-52.
2003: Gales Ana C; Tognim Maria C B; Reis Adriana O; Jones Ronald N; Sader Hélio S
Emergence of an IMP-like metallo-enzyme in an Acinetobacter baumannii clinical strain from a Brazilian teaching hospital.
Diagnostic microbiology and infectious disease 2003;45(1):77-9.
2003: Castanheira Mariana; Jones Ronald N; Silbert Suzane; Brandileone Maria C C; Sader Hélio S
Typing and molecular characterization of Streptococcus pneumoniae with reduced susceptibility to cefotaxime isolated in Latin America.
Microbial drug resistance (Larchmont, N.Y.) 2003;9(4):345-51.
2002: Bantar C; Bavestrello L; Curcio D; Jasovich A; Absi Rubén; Bagnulo Homero; Famiglietti Angela; García Patricia; Labarca Jaime; Mera Jorge; Pedreira Walter; Sader Helio; Thompson Luis; Wey Sergio;
Acute community-acquired pneumonia in adults: guidelines for initial antimicrobial therapy based on local evidence from a South American Working Group (ConsenSur).
Journal of chemotherapy (Florence, Italy) 2002;14 Suppl 4():1-22.
2002: López H; Sader H; Amábile C; Pedreira W; Muñoz Bellido J L; García Rodríguez J A;
[In vitro activity of moxifloxacin against respiratory pathogens in Latin America]
Revista española de quimioterapia : publicación oficial de la Sociedad Española de Quimioterapia 2002;15(4):325-34.
2002: Bantar C; Bavestrello L; Curcio D; Jasovich A; Absi Rubén; Bagnulo Homero; Famiglietti Angela; García Patricia; Labarca Jaime; Mera Jorge; Pedreira Walter; Sader Helio; Thompson Luis; Wey Sergio;
Acute community-acquired pneumonia in adults: guidelines for initial antimicrobial therapy based on local evidence from a South American working group (ConsenSur).
Journal of chemotherapy (Florence, Italy) 2002;14(6):635-6.
2002: Gales Ana C; Sader Helio S; Mendes Rodrigo E; Jones Ronald N
Salmonella spp. isolates causing bloodstream infections in Latin America: report of antimicrobial activity from the SENTRY Antimicrobial Surveillance Program (1997-2000).
Diagnostic microbiology and infectious disease 2002;44(3):313-8.
2002: Gales Ana C; Sader Helio S; Jones Ronald N;
Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000).
Diagnostic microbiology and infectious disease 2002;44(3):289-99.
2002: Sader Helio S; Jones Ronald N; Silva Juliana B;
Skin and soft tissue infections in Latin American medical centers: four-year assessment of the pathogen frequency and antimicrobial susceptibility patterns.
Diagnostic microbiology and infectious disease 2002;44(3):281-8.
2002: Sader Helio S; Jones Ronald N; Andrade-Baiocchi Soraya; Biedenbach Douglas J;
Four-year evaluation of frequency of occurrence and antimicrobial susceptibility patterns of bacteria from bloodstream infections in Latin American medical centers.
Diagnostic microbiology and infectious disease 2002;44(3):273-80.
2002: da Cunha Clovis Arns; Sader Helio S; Nicodemo Antonio C;
Antimicrobial therapy for community-acquired pneumonia in adults.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2002;6(2):82-7.
2002: Cereda Rosangela F; Gales Ana C; Silbert Suzane; Jones Ronald N; Sader Helio S
Molecular typing and antimicrobial susceptibility of vancomycin-resistant Enterococcus faecium in Brazil.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2002;23(1):19-22.
2001: Critchley I A; Blosser R S; Karlowsky J A; Yamakita J; Barth A; Sader H S; Mendes C; Teixeira L; Rossi F; Dias C A; Jones M E; Thornsberry C; Sahm D F
Antimicrobial resistance in respiratory pathogens isolated in Brazil during 1999-2000.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2001;5(6):294-304.
2001: Silbert S; Barth A L; Sader H S
Heterogeneity of Pseudomonas aeruginosa in Brazilian cystic fibrosis patients.
Journal of clinical microbiology 2001;39(11):3976-81.
2001: Reis A O; Cordeiro J C; Machado A M; Sader H S
In vitro antimicrobial activity of linezolid tested against vancomycin-resistant enterococci isolated in Brazilian hospitals.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2001;5(5):243-51.
2001: Pfaller M A; Diekema D J; Jones R N; Sader H S; Fluit A C; Hollis R J; Messer S A;
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobial surveillance program.
Journal of clinical microbiology 2001;39(9):3254-9.
2001: Sader H S; Gales A C; Pfaller M A; Mendes R E; Zoccoli C; Barth A; Jones R N
Pathogen frequency and resistance patterns in Brazilian hospitals: summary of results from three years of the SENTRY Antimicrobial Surveillance Program.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2001;5(4):200-14.
2001: Sader H S; Gales A C; Jones R N
Antimicrobial activity of linezolid against Gram-positive cocci isolated in Brazil.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2001;5(4):171-6.
2001: Cordeiro J C; Reis A O; Miranda E A; Sader H S;
In vitro antimicrobial activity of the aminoglycoside arbekacin tested against oxacillin-resistant Staphylococcus aureus isolated in Brazilian hospitals.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2001;5(3):130-5.
2001: Pfaller M A; Acar J; Jones R N; Verhoef J; Turnidge J; Sader H S
Integration of molecular characterization of microorganisms in a global antimicrobial resistance surveillance program.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32 Suppl 2():S156-67.
2001: Gales A C; Jones R N; Forward K R; Liñares J; Sader H S; Verhoef J
Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY Antimicrobial Surveillance Program (1997-1999).
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;32 Suppl 2():S104-13.
2001: Gales A; Sader H; Jones R N;
Activities of BMS 284756 (T-3811) against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae isolates from SENTRY antimicrobial surveillance program medical centers in Latin America (1999).
Antimicrobial agents and chemotherapy 2001;45(5):1463-6.
2001: Cereda R; Sader H; Sejas L; Machado A; Zanatta Y; Rego S; Medeiros E
Enterococcus faecalis resistant to vancomycin and teicoplanin (VanA phenotype) isolated from a bone marrow transplanted patient in Brazil.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2001;5(1):40-6.
2001: Sader H S; Jones R N; Ballow C H; Biedenbach D J; Cered R F;
Antimicrobial susceptibility of quinupristin/dalfopristin tested against gram-positive cocci from Latin America: results from the global SMART (GSMART) surveillance study.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2001;5(1):21-31.
2001: Sader H S; Gales A C
Emerging strategies in infectious diseases: new carbapenem and trinem antibacterial agents.
Drugs 2001;61(5):553-64.
2000: Sader H; Del'Alamo L
Etest compared to broth microdilution: discrepant results when testing macrolides against Streptococcus pneumoniae indicate a need for better clinical and serum level/MIC correlation.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2000;4(5):268-70.
2000: Sader H S; Gales A C; Granacher T D; Pfaller M A; Jones R N;
Prevalence of antimicrobial resistance among respiratory tract isolates in Latin America: results from SENTRY antimicrobial surveillance program (1997-98).
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2000;4(5):245-54.
2000: Roland R K; Mendes R E; Silbert S; Bolsoni A P; Sader H S
In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactams.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2000;4(5):226-35.
2000: Lewis M T; Gales A C; Sader H S; Pfaller M A; Jones R N
Frequency of occurrence and antimicrobial susceptibility patterns for pathogens isolated from latin american patients with a diagnosis of pneumonia: results from the SENTRY antimicrobial surveillance program (1998).
Diagnostic microbiology and infectious disease 2000;37(1):63-74.
2000: Critchley I A; Thornsberry C; Piazza G; Jones M; Hickey M L; Barth A L; Mendes C; Rossi F F; Sader H S; Teixeira L M; Sahm D F
Antimicrobial susceptibility of Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis collected from five centers in Brazil, 1997-98.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2000;6(4):178-84.
2000: Sader H S
Antimicrobial resistance in Brazil: comparison of results from two multicenter studies.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2000;4(2):91-9.
2000: Guzmán-Blanco M; Casellas J M; Sader H S
Bacterial resistance to antimicrobial agents in Latin America. The giant is awakening.
Infectious disease clinics of North America 2000;14(1):67-81, viii.
2000: Gales A C; Jones R N; Gordon K A; Sader H S; Wilke W W; Beach M L; Pfaller M A; Doern G V
Activity and spectrum of 22 antimicrobial agents tested against urinary tract infection pathogens in hospitalized patients in Latin America: report from the second year of the SENTRY antimicrobial surveillance program (1998).
The Journal of antimicrobial chemotherapy 2000;45(3):295-303.
2000: Pfaller M A; Jones R N; Doern G V; Sader H S; Messer S A; Houston A; Coffman S; Hollis R J
Bloodstream infections due to Candida species: SENTRY antimicrobial surveillance program in North America and Latin America, 1997-1998.
Antimicrobial agents and chemotherapy 2000;44(3):747-51.
2000: Sader H S; Tosin I; Sejas L; Miranda E
Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
The Brazilian journal of infectious diseases : an official publication of the Brazilian Society of Infectious Diseases 2000;4(1):22-8.
2000: Diekema D J; Pfaller M A; Jones R N; Doern G V; Kugler K C; Beach M L; Sader H S
Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group.
International journal of antimicrobial agents 2000;13(4):257-71.
2000: Gales A C; Jones R N; Pfaller M A; Gordon K A; Sader H S
Two-year assessment of the pathogen frequency and antimicrobial resistance patterns among organisms isolated from skin and soft tissue infections in Latin American hospitals: results from the SENTRY antimicrobial surveillance program, 1997-98. SENTRY Study Group.
International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases 2000;4(2):75-84.
1999: Diekema D J; Pfaller M A; Jones R N; Doern G V; Winokur P L; Gales A C; Sader H S; Kugler K; Beach M
Survey of bloodstream infections due to gram-negative bacilli: frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY Antimicrobial Surveillance Program, 1997.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(3):595-607.
1999: Pfaller M A; Jones R N; Doern G V; Fluit A C; Verhoef J; Sader H S; Messer S A; Houston A; Coffman S; Hollis R J
International surveillance of blood stream infections due to Candida species in the European SENTRY Program: species distribution and antifungal susceptibility including the investigational triazole and echinocandin agents. SENTRY Participant Group (Europe).
Diagnostic microbiology and infectious disease 1999;35(1):19-25.
1999: Arruda E A; Marinho I S; Boulos M; Sinto S I; Caiaffa H H; Mendes C M; Oplustil C P; Sader H; Levy C E; Levin A S
Nosocomial infections caused by multiresistant Pseudomonas aeruginosa.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1999;20(9):620-3.
1999: Del' Alamo L; Cereda R F; Tosin I; Miranda E A; Sader H S
Antimicrobial susceptibility of coagulase-negative staphylococci and characterization of isolates with reduced susceptibility to glycopeptides.
Diagnostic microbiology and infectious disease 1999;34(3):185-91.
1999: Pfaller M A; Jones R N; Doern G V; Sader H S; Kugler K C; Beach M L
Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. SENTRY Participants Group.
Diagnostic microbiology and infectious disease 1999;33(4):283-97.
1998: Sader H S; Jones R N; Gales A C; Winokur P; Kugler K C; Pfaller M A; Doern G V
Antimicrobial susceptibility patterns for pathogens isolated from patients in Latin American medical centers with a diagnosis of pneumonia: analysis of results from the SENTRY Antimicrobial Surveillance Program (1997). SENTRY Latin America Study Group.
Diagnostic microbiology and infectious disease 1998;32(4):289-301.
1998: Sader H S; Mendes C M; Montelli A; Sampaio J; Segura A J; Kesselring G L; Costa L; Ribeiro J E; Mamizuka E; Mimiça I
[In vitro antimicrobial activity of cefpirome compared to other broad-spectrum beta-lactam drugs against 804 clinical isolates from 9 Brazilian hospitals]
Revista da Associação Médica Brasileira (1992) 1998;44(4):283-8.
1998: Jones M E; Jones R N; Sader H; Verhoef J; Acar J
Current susceptibilities of staphylococci to glycopeptides determined as part of an international resistance surveillance programme. Sentry Antimicrobial Surveillance Program.
The Journal of antimicrobial chemotherapy 1998;42(1):119-21.
1998: Pfaller M A; Jones R N; Doern G V; Sader H S; Hollis R J; Messer S A
International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Participant Group.
Journal of clinical microbiology 1998;36(7):1886-9.
1998: Sesso R; Barbosa D; Leme I L; Sader H; Canziani M E; Manfredi S; Draibe S; Pignatari A C
Staphylococcus aureus prophylaxis in hemodialysis patients using central venous catheter: effect of mupirocin ointment.
Journal of the American Society of Nephrology : JASN 1998;9(6):1085-92.
1997: Saraiva I H; Jones R N; Erwin M; Sader H S
[Evaluation of antimicrobial sensitivity of 87 clinical isolates of vancomycin-resistant enterococci]
Revista da Associação Médica Brasileira (1992) 1997;43(3):217-22.
1997: Farias W V; Sader H S; Leme I L; Pignatari A C
[Sensitivity pattern of 117 clinical isolates of Staphylococcus aureus from 12 hospitals]
Revista da Associação Médica Brasileira (1992) 1997;43(3):199-204.
1997: Sader H S; Mimiça I; Rossi F; Zoccoli C; Montelli A C; Sampaio J L; Segura A J; Magalhães M; Nowakonski A; Mendes C M
Evaluation of the in vitro activity of cefepime compared to other broad-spectrum cephalosporins against clinical isolates from eighteen Brazilian hospitals by using the Etest.
Diagnostic microbiology and infectious disease 1997;28(2):87-92.
1997: Gales A C; Pignatari A C; Jones R N; Baretta M; Sader H S
[Evaluation of in vitro activity of new fluoroquinolones, cephalosporins and carbapenems against 569 gram-negative bacteria]
Revista da Associação Médica Brasileira (1992) 1997;43(2):137-44.
1996: Gales A C; Sader H S; Sinto S; Santos O P; Mendes C M
In vitro activity of ampicillin-sulbactam against clinical multiresistant Acinetobacter baumannii isolates.
Journal of chemotherapy (Florence, Italy) 1996;8(6):416-9.
1996: Sader H S; Mendes C F; Pignatari A C; Pfaller M A
Use of macrorestriction analysis to demonstrate interhospital spread of multiresistant Acinetobacter baumannii in São Paulo, Brazil.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1996;23(3):631-4.
1996: Mimica I; Mendes C M; Mimica L; Oplustil C; Pignatari A C; Sader H
[Study of the susceptibility of Staphylococcus sp. and Enterococcus sp. to teicoplanin and vancomycin]
Revista da Associação Médica Brasileira (1992) 1996;42(3):147-50.
1996: Cereda R F; Pignatari A C; Leme I L; Jones R N; Sader H S
[In vitro susceptibility testing of 446 clinical isolates of gram-positive bacteria to new quinolones, carbapenems and cephalosporins]
Revista da Associação Médica Brasileira (1992) 1996;42(3):130-4.
1996: Levin A S; Mendes C M; Sinto S I; Sader H S; Scarpitta C R; Rodrigues E; Sauaia N; Boulos M
An outbreak of multiresistant Acinetobacter baumanii in a university hospital in São Paulo, Brazil.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1996;17(6):366-8.
1995: Sader H S; Jones R N; Pfaller M A
Relapse of catheter-related Flavobacterium meningosepticum bacteremia demonstrated by DNA macrorestriction analysis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;21(4):997-1000.
1995: Sader H S; Biedenbach D; Jones R N
Evaluation of Vitek and API 20S for species identification of enterococci.
Diagnostic microbiology and infectious disease 1995;22(4):315-9.
1995: Sader H S; Hollis R J; Pfaller M A
The use of molecular techniques in the epidemiology and control of infectious diseases.
Clinics in laboratory medicine 1995;15(2):407-31.
1995: Sader H S; Jones R N
[Cephalosporins: 4 generations of structural evolution]
Revista da Associação Médica Brasileira (1992) 1995;41(2):144-50.
1995: Jones R N; Sader H S; Erwin M E; Anderson S C
Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the United States. Enterococcus Study Group.
Diagnostic microbiology and infectious disease 1995;21(2):85-93.
1995: Sader H S; Runyon B A; Erwin M E; Jones R N
Antimicrobial activity of 11 newer and investigational drugs tested against aerobic isolates from spontaneous bacterial peritonitis.
Diagnostic microbiology and infectious disease 1995;21(2):105-10.
1994: Sader H S; Pfaller M A; Jones R N
Prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States. II. Study of the intra- and interlaboratory dissemination of extended-spectrum beta-lactamase-producing Enterobacteriaceae.
Diagnostic microbiology and infectious disease 1994;20(4):203-8.
1994: Sader H S; Pfaller M A; Tenover F C; Hollis R J; Jones R N
Evaluation and characterization of multiresistant Enterococcus faecium from 12 U.S. medical centers.
Journal of clinical microbiology 1994;32(11):2840-2.
1994: Jones R N; Sader H S; Erwin M E
Update of lomefloxacin in vitro activity and spectrum. A multicenter trial testing contemporary pathogens following Food and Drug Administration validation guidelines. Lomefloxacin Activity Study Group.
Diagnostic microbiology and infectious disease 1994;20(2):93-8.
1994: Sader H S; Pignatari A C
E test: a novel technique for antimicrobial susceptibility testing.
São Paulo medical journal = Revista paulista de medicina 1994;112(4):635-8.
1994: Sader H S; Jones R N
In vitro antimicrobial activity of cefpirome against ceftazidime-resistant isolates from two multicenter studies.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1994;13(8):675-9.
1994: Sader H S; Perl T M; Hollis R J; Divishek D; Herwaldt L A; Jones R N
Nosocomial transmission of Serratia odorifera biogroup. 2: Case report demonstration by macrorestriction analysis of chromosomal DNA using pulsed-field gel electrophoresis.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1994;15(6):390-3.
1994: Sader H S; Pignatari A C; Hollis R J; Jones R N
Evaluation of interhospital spread of methicillin-resistant Staphylococcus aureus in Sao Paulo, Brazil, using pulsed-field gel electrophoresis of chromosomal DNA.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1994;15(5):320-3.
1994: Sader H S; Pignatari A C; Frei R; Hollis R J; Jones R N
Pulsed-field gel electrophoresis of restriction-digested genomic DNA and antimicrobial susceptibility of Xanthomonas maltophilia strains from Brazil, Switzerland and the USA.
The Journal of antimicrobial chemotherapy 1994;33(3):615-8.
1993: Sader H S; Jones R N; Allen S D; Gerlach E H; Murray P R; Washington J A
In vitro comparison activity of OPC-17116, a new fluoroquinolone, against more than 5,000 recent clinical isolates from five medical centers.
Journal of chemotherapy (Florence, Italy) 1993;5(5):283-8.
1993: Sader H S; Jones R N; Washington J A; Murray P R; Gerlach E H; Allen S D; Erwin M E
In vitro activity of cefpodoxime compared with other oral cephalosporins tested against 5556 recent clinical isolates from five medical centers.
Diagnostic microbiology and infectious disease 1993;17(2):143-50.
1993: Sader H S; Pignatari A C; Leme I L; Burattini M N; Tancresi R; Hollis R J; Jones R N
Epidemiologic typing of multiply drug-resistant Pseudomonas aeruginosa isolated from an outbreak in an intensive care unit.
Diagnostic microbiology and infectious disease 1993;17(1):13-8.
1993: Sader H S; Pignatari A C; Hollis R J; Leme I; Jones R N
Oxacillin- and quinolone-resistant Staphylococcus aureus in Sao Paulo, Brazil: a multicenter molecular epidemiology study.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 1993;14(5):260-4.
1993: Sader H S; Jones R N
Antimicrobial activity of the new carbapenem biapenem compared to imipenem, meropenem and other broad-spectrum beta-lactam drugs.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1993;12(5):384-91.
1992: Sader H S; Jones R N
Cefotaxime is extensively used for surgical prophylaxis.
American journal of surgery 1992;164(4A Suppl):28S-38S.
1992: Sader H S; Erwin M E; Jones R N
In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1992;11(4):372-81.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Helio Sader

Research Profile (preview)

Procedures

Chemicals & Drugs

Physiology

Living Beings

Geographic Areas

Disorders

Concepts & Ideas

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Helio Sader (preview)

All Publications